Skip to content
ALM

Alamar Biosciences

ALMR

Alamar Biosciences is a biotechnology company in the healthcare sector trading on XNAS, led by CEO Justin J. McAnear, with a market cap of $1.5B.

Market cap
$1.52B-6.4%

Earnings

Next report

Aug 14, 2026 (in 2 months)
Revenue estimate$25.9M
EPS estimate-$0.36

Financials

Q1 2026

Income statement

See full
Revenue$26.0M+98.9%
Gross profit$14.5M+126%
Operating income-$12.3M-44.4%
Net income-$21.3M-178%
EPS (diluted)-$1.74-156%

Balance sheet

See full
Cash & equivalents$64.6M
Total debt$30.6M
Total equity-$178.1M
Total assets$186.5M

Cash flow

See full
Operating cash flow-$20.3M-55.7%
CapEx$600.0K+8.3%
Free cash flow-$20.9M-53.8%

Valuation & ratios

Valuation

See full
Market cap$1.52B
Enterprise value$1.49B

Returns & leverage

See full
Debt / equity-0.2×
Current ratio5.9×

Segments

By geography

See full
EMEA$4.0M+179%
Asia Pacific$2.4M+435%
Americas$1.3M+6,335%

By product

See full
Consumables$14.0M+178%
Instruments$7.4M+78.0%
Service$4.7M+27.8%

Profile

Listed2026
CEOJustin J. McAnear
FilingsSEC EDGAR

Questions, answered.

What is Alamar Biosciences 's market cap?
Alamar Biosciences (ALMR) has a market capitalization of $1.5B and trades on XNAS.
Where is Alamar Biosciences headquartered?
Alamar Biosciences is headquartered in United States of America. It has been publicly traded since 2026.